Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in TRAW — Traws Pharma, Inc.

CIK 73124 CHICAGO, IL
Back to TRAW Full portfolio

Position in TRAW

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$31,461
+$17,667 QoQ
Shares Held
37,454
+2955.0% QoQ
Ownership
0.244%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 34 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRAW Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. TRAW ranks #396 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in TRAW

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $31,461 37,454
2024-06-30 $13,794 30,655
2024-03-31 $31,090 30,783
2023-12-31 $23,087 30,783
2023-09-30 $21,855 30,783
2023-06-30 $36,323 30,783
2023-03-31 $22,471 30,783
2022-12-31 $20,008 30,783
2022-09-30 $27,089 30,783
2022-06-30 $40,633 30,783
2022-03-31 $56,640 30,783
2021-12-31 $78,496 30,783
2021-09-30 $117,898 30,783
2021-06-30 $223,825 32,298